Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Gilleleje wellness ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   5.5% 5.5% 5.5% 5.5% 5.5% 5.5% 5.5% 5.5%   Bankruptcy risk   7.2% 7.2% 4.7% 5.3% 5.2% 7.3% 14.9% 14.6%   Credit score (0-100)   35 35 45 41 42 32 14 15   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   799 1,748 1,691 1,676 1,795 1,815 1,815 1,815   Gross profit   494 1,002 915 1,022 1,113 959 0.0 0.0   EBITDA   84.7 61.5 304 65.7 129 -84.1 0.0 0.0   EBIT   55.0 34.2 304 65.7 129 -84.1 0.0 0.0   Pre-tax profit (PTP)   52.7 31.2 302.6 55.6 121.6 -91.1 0.0 0.0   Net earnings   42.3 24.2 234.5 43.1 94.2 -70.7 0.0 0.0   Pre-tax profit without non-rec. items   52.7 31.2 303 55.6 122 -91.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   92.3 116 351 394 488 418 368 368   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   358 287 638 448 608 508 368 368   Net Debt   -198 -147 -469 -270 -325 -170 -368 -368     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   799 1,748 1,691 1,676 1,795 1,815 1,815 1,815   Net sales growth   0.0% 118.8% -3.3% -0.9% 7.2% 1.1% 0.0% 0.0%   Gross profit   494 1,002 915 1,022 1,113 959 0.0 0.0   Gross profit growth   0.0% 103.0% -8.7% 11.7% 8.9% -13.8% -100.0% 0.0%   Employees   0 0 0 0 0 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   -409.2 -941.0 -611.3 -956.3 -984.6 -1,043.6 0.0 0.0   Balance sheet total (assets)   358 287 638 448 608 508 368 368   Balance sheet change%   0.0% -19.9% 122.8% -29.9% 35.9% -16.5% -27.7% 0.0%   Added value   493.8 1,002.5 915.0 1,022.0 1,113.3 959.5 0.0 0.0   Added value %   61.8% 57.4% 54.1% 61.0% 62.0% 52.9% 0.0% 0.0%   Investments   -2 -54 0 0 0 0 0 0   Net sales trend   0.0 1.0 -1.0 -2.0 1.0 2.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   10.6% 3.5% 18.0% 3.9% 7.2% -4.6% 0.0% 0.0%   EBIT %   6.9% 2.0% 18.0% 3.9% 7.2% -4.6% 0.0% 0.0%   EBIT to gross profit (%)   11.1% 3.4% 33.2% 6.4% 11.6% -8.8% 0.0% 0.0%   Net Earnings %   5.3% 1.4% 13.9% 2.6% 5.2% -3.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   9.0% 2.9% 13.9% 2.6% 5.2% -3.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   6.6% 1.8% 17.9% 3.3% 6.8% -5.0% 0.0% 0.0%   ROA %   15.4% 10.6% 65.7% 12.1% 24.4% -15.1% 0.0% 0.0%   ROI %   59.6% 32.8% 130.0% 17.6% 29.2% -18.6% 0.0% 0.0%   ROE %   45.8% 23.2% 100.3% 11.6% 21.4% -15.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   25.8% 40.6% 55.0% 88.0% 80.3% 82.2% 100.0% 100.0%   Relative indebtedness %   33.2% 9.7% 17.0% 3.2% 6.7% 5.0% 0.0% 0.0%   Relative net indebtedness %   8.5% 1.3% -10.7% -12.9% -11.4% -4.4% -20.3% -20.3%   Net int. bear. debt to EBITDA, %   -233.6% -239.1% -154.4% -411.2% -252.2% 202.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.0 1.9 6.6 3.2 3.1 0.0 0.0   Current Ratio   1.2 1.7 2.2 8.4 5.1 5.6 0.0 0.0   Cash and cash equivalent   197.7 147.0 469.1 270.0 324.6 170.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   10.1 6.6 9.2 13.3 11.8 22.6 0.0 0.0   Trade creditors turnover (days)   95.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   41.4% 16.4% 37.8% 26.7% 33.9% 28.0% 20.3% 20.3%   Net working capital   65.0 116.5 351.0 394.1 488.3 417.6 0.0 0.0   Net working capital %   8.1% 6.7% 20.8% 23.5% 27.2% 23.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 454 0 0   Added value / employee   0 0 0 0 0 240 0 0   Employee expenses / employee   0 0 0 0 0 -261 0 0   EBITDA / employee   0 0 0 0 0 -21 0 0   EBIT / employee   0 0 0 0 0 -21 0 0   Net earnings / employee   0 0 0 0 0 -18 0 0